Skip to main content
. Author manuscript; available in PMC: 2014 Jan 23.
Published in final edited form as: Future Virol. 2013 Dec 1;8(12):1151–1160. doi: 10.2217/fvl.13.107

Figure 2.

Figure 2

Figure 2

ELISA response following vAM409 vaccination. A) Antibody titers in response to vaccine (V) or placebo (P) were compared at multiple time points post-immunization. Antibodies titers (mean ± SE) were measured by ELISA using sonicated, clarified guinea pig lung fibroblast lysate from GPCMV-infected cells as previously described [13]. A control ELISA titer obtained using a polyclonal anti-GPCMV antisera from an animal inoculated with wild-type GPCMV is shown for comparison. B) Western blot demonstrating evolution of antibody response following vAM409 immunization. Immunized animals evolve antibody responses that include gB (GP58) as evidenced by comparison with a monospecific anti-gB polyclonal antibody (arrowhead).